MARATTO

article · Radiology Case Reports

Favorable evolution of a pseudoaneurysm of the aortic arch in Behçet's disease under medical treatment: A case report

2024Open accessMohammed V University

Abstract

Behçet's disease is a multisystem vasculitis of undefined etiology. Aneurysms or pseudoaneurysms of the aortic arch constitute one of the major complications during the course of Behçet's disease. We report the case of a patient who presented for a consultation due to chest pain. The diagnosis of Behçet's disease was made based on clinical arguments, the pathergic test, and was confirmed by a thoracic angioscanner that revealed a 30 mm pseudoaneurysm of the aortic arch. Given the urgency of the treatment, a 3-day bolus of Solu-Medrol was administered, followed by oral treatment. After 12 months of follow-up, the patient reported a marked clinical improvement. The control angioscanner indicated an almost complete disappearance of the pseudoaneurysm of the aortic arch. The thoracic involvement of angio-Behçet is severe and poses a risk to vital prognosis; the choice between surgical treatment and medical monitoring is very difficult. In this article, we present a rare and significant evolution that opens up a substantial discussion on the role of immunosuppressive treatment in the management of pseudoaneurysms revealed by Behçet's disease.

Research topics

  • Ocular Diseases and Behçet’s Syndrome
  • Retinal and Optic Conditions
  • Vasculitis and related conditions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.radcr.2024.10.041

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.